Medical Device | April 05, 2022
Agilent joins AMBIC to advance biomanufacturing
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
A staggering 65% of the TB cases in India are in the 15-45 age group
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Subscribe To Our Newsletter & Stay Updated
